ProAxsis and Aptamer Group, the developer of custom affinity ligands to enable the life science industry through its proprietary OptimerTM platform announce a partnership to develop Optimer ligands for ProAxsis’s diagnostic assays. Aptamer Group will develop validated Optimer ligands against critical targets for ProAxsis’s diagnostic assays.(August 2021) - ProAxsis

Our website is currently being updated and you may experience some limited functionality at this time.

ProAxsis and Aptamer Group, the developer of custom affinity ligands to enable the life science industry through its proprietary OptimerTM platform announce a partnership to develop Optimer ligands for ProAxsis’s diagnostic assays. Aptamer Group will develop validated Optimer ligands against critical targets for ProAxsis’s diagnostic assays.(August 2021)

WP_Developer

November 11, 2022

Recent Posts

American Thoracic Society Annual Meeting Washington DC, 19-24 May 2023

November 11, 2022

Association of Medical Diagnostics Manufacturers IVD Regulatory Meeting Bethesda, MD 19-20 April,2023

November 11, 2022

Texas Lung Cancer Conference Austin, TX 30March – 1April 2023

November 11, 2022

Have Any Questions?

Categories

November 11, 2022

Share This :